These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2901759)

  • 21. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic component of neuroleptic receptors.
    Leysen JE; Niemegeers CJ; Tollenaere JP; Laduron PM
    Nature; 1978 Mar; 272(5649):168-71. PubMed ID: 564466
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W; Curtin J; Fields J
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
    Fuchs V; Coper H; Strauss S; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice.
    Randall PK; Severson JA; Hurd SM; McClure WO
    Brain Res; 1985 Apr; 333(1):85-95. PubMed ID: 4039618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M; Bannet J; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M; Hermans E; Maloteaux JM
    Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
    Kinon BJ; Kane JM
    Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.